Dr. Avtar Dhillon reports

EMERALD HEALTH THERAPEUTICS EXPANDS DISTRIBUTION OF ITS SYNC 25 CBD OIL TO TWO MORE CANADIAN PROVINCES

Emerald Health Therapeutics Inc. has shipped 9,960 40-millilitre units of its SYNC 25 CBD oil to Alberta and Saskatchewan. The Emerald-branded indica-dominant CBD oil offers consumers a smoke-free product alternative.

"CBD oil has become an increasingly popular product on the market today, and our cannabis-derived SYNC 25 is an example of the high-quality products that consumers can expect from Emerald," said Dr. Avtar Dhillon, president and executive chairman of Emerald. "With our range of expertise in the research and development of science-driven products, we will continue to expand our product portfolio and meet consumer demand."

SYNC 25 has been shipped to Alberta Gaming, Liquor and Cannabis and to private retailers authorized by the Saskatchewan Liquor and Gaming Authority. In May, Emerald shipped 6,000 40 ml units of SYNC 25 to the British Columbia Liquor Distribution Branch.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a Canadian licensed producer of cannabis products, with strategic initiatives focused on differentiated, value-added product development for medical and adult-use customers supported by novel intellectual property, large-scale cultivation, extraction and softgel encapsulation, as well as unique marketing and distribution channels. Its 50-per-cent-owned Pure Sunfarms operation in British Columbia is in full production in its first 1.1-million-square-foot greenhouse, with growing capacity of approximately 75,000 kilograms; a second 1.1-million-square-foot greenhouse is planned to be in full production by the end of 2020.

We seek Safe Harbor.